Media Outlets Discuss Newly Approved Ebola Vaccine From Merck, Trial In DRC Outbreak Of Experimental Vaccine From J&J

DW: New Ebola vaccine enters real-world DRC test phase
“Health authorities in the Democratic Republic of Congo started using a new vaccine to control the outbreak of the deadly Ebola virus, global health NGO Médecins Sans Frontières (MSF) said on Thursday…” (11/14).

The Hill: Ebola vaccine approved
“…By prequalifying the [newly approved Merck Ebola] vaccine, the WHO hopes to accelerate its dissemination, allowing United Nations agencies and Gavi, the Vaccine Alliance, to obtain and distribute the vaccine. Merck says that it will work with the Food and Drug Administration in the U.S. as well as agencies across Africa to secure broader approval…” (Fox, 11/14).

Additional coverage is available from Al Jazeera.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.